Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2023-05-24 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase activities and changes in issued shares, which aligns with announcements of share buybacks or capital changes. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure form specific to share repurchases and capital changes. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a formal disclosure of share repurchase transactions.
2023-05-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that the repurchases were made in accordance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a full financial report or earnings release. It is a formal regulatory filing required by the Stock Exchange of Hong Kong to disclose share capital changes and share buybacks. The document is not an announcement of a report but the actual disclosure itself. Therefore, it fits best under the category of Transaction in Own Shares (POS).
2023-05-23 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report or earnings release. It is not a report publication announcement since it contains substantive data about share repurchases. The content fits the description of a 'Transaction in Own Shares' filing, which reports on the company's buyback of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length and detail support a high confidence score.
2023-05-19 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report or earnings release. It is a formal notification of share buybacks and capital changes as required by the Stock Exchange of Hong Kong rules. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback or sale of its own shares. The document length is over 11,000 characters and contains substantive data about share repurchases, confirming it is not a mere announcement or certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-05-18 English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON ENCOURAGING PHASE I CLINICAL DATA OF TST002 (BLOSOZUMAB) IN CHINESE PATIENTS WITH REDUCED BONE MINERAL DENSITY
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Transcenta Holding Limited providing a business update on encouraging Phase I clinical data of a drug candidate (TST002/Blosozumab). It discusses clinical trial results, safety, efficacy, and future plans for Phase II studies. There is no indication that this is a full financial report, audit report, earnings release, or regulatory filing. It is a business update announcement related to clinical development progress, not a financial or governance report. The document is about a clinical data update and business progress, which fits best under a general regulatory announcement or business update category. Given the available categories, the closest fit is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other specific categories. The document is not a report publication announcement since it contains substantive content rather than just a notice of report availability. Confidence is high as the content clearly does not match other categories.
2023-05-17 English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS
Report Publication Announcement Classification · 95% confidence The document is a notification to non-registered shareholders about the publication of a circular and notice of the annual general meeting on the company's website. It includes a request form for shareholders to receive printed copies of corporate communications such as circulars, notices of meetings, and reports. The document does not contain actual financial data or detailed report content but rather informs shareholders about the availability of these documents and how to request printed copies. It explicitly mentions the circular relates to re-election of directors, share repurchase mandates, adoption of new articles, share incentive scheme awards, and AGM notice. This is an announcement about the publication of meeting materials and related corporate communications, not the materials themselves. Therefore, it fits the category of Report Publication Announcement (RPA).
2023-05-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.